pharmaphorum

JULY 15, 2022

.” KW-6356 is a follow-up to Kyowa Kirin’s first-generation adenosine A2 antagonist Nourianz/Nouriast (istradefylline), which finally claimed FDA approval in 2019 as an add-on to levodopa in Parkinson’s after more than two decades of R&D and has been available in Japan since 2013. billion yen (around $68 million).

Competition 59

Competition Marketing Medicine FDA 59

European Pharmaceutical Review

OCTOBER 19, 2022

2 Recently, the US Patent and Trademark Office (US PTO) reiterated the concern that patents have been “misused to inhibit and delay – for years and even decades – competition from generic drugs and biosimilars, denying Americans access to lower-cost drugs.” 23 April 2013. Santa Clara High Technology Law Journal. 29(3), article 2.

Food and Drug Administration 96

Food and Drug Administration Pharmaceutical products Pharmaceutical FDA 96

European Pharmaceutical Review

NOVEMBER 8, 2022

Under two other pending bills – House of Representatives Bill 2883, titled Stop Stalling Access to Affordable Medications, and Senate Bill 1425, titled Stop STALLING 4 Act – it would be unfair competition to submit an “objectively baseless petition” to the FDA in an attempt to interfere with a competitor’s application to market a drug.

Food and Drug Administration 52

Food and Drug Administration Pharma Manufacturing Prescription 52

Pharmaceutical Technology

OCTOBER 5, 2022

However, new MS drugs like Novartis ’ Gilenya, were going to soon enter the market and increase competition within the MS therapeutic landscape. More recently, Biogen has been facing competition from dimethyl fumarate generics. This prevents the development of B lymphocytes and macrophages, which contribute to the pathology of MS.

Government 59

Government Specialization Physicians Education 59

Rep-Lite

JULY 16, 2020

Founded in 2013, Rep-Lite has transformed how medical manufacturers achieve success by offering a results-proven model allowing for the preservation of time and resources while also increasing quality service. Top employers in the area include AT&T, Fiserv., LexisNexis, HP, Verizon, and UPS, to name just a few.

Manufacturing 52

Manufacturing Sales Education Medical 52

Clarivate

MAY 31, 2023

Pharma M&A activity was muted in 2022, coming in at its lowest level since 2013 – something of a surprise, given the looming patent cliff and pharma’s past reliance on M&A and biopartnering as a quick fix for revenues lost to generics and biosimilars competition. Together, these three drugs made $29.8 billion in 2022.

Pharma 52

Pharma Biopharma Medicine Healthcare 52

European Pharmaceutical Review

DECEMBER 26, 2023

2 Capabilities in suspension cell lines and proprietary cell lines are becoming increasingly important to competitiveness within the gene therapy industry. He was named Head of Process Development in 2013, then promoted to Chief Scientific Officer (CSO) in 2020.

Manufacturing 98

Manufacturing Safety Patients Competition 98

Pharmaceutical Technology

SEPTEMBER 22, 2022

In 2013, the FDA first approved Vazkepa solely for the reduction of triglyceride levels for hypertriglyceridemia. The company now faces a highly competitive generics market for its lead drug. According to GlobalData, there are currently 135 therapeutics being developed for cardiovascular disease. Amarin’s net product revenue was $577.9

Pharmaceutical 52

Pharmaceutical Marketing FDA Leads 52

European Pharmaceutical Review

NOVEMBER 30, 2023

Overall, as summarised in CGT’s GMP Manufacturing report, among a challenging global economic landscape, intense global competition and technology innovation persisting at the forefront of change in the cell and gene therapy industry, immediate action is needed to support the future of the sector.

Manufacturing 97

Manufacturing Recruitment Medicine Biopharma 97

PM360

MAY 15, 2023

The Point of Care Marketing Association (POCMA) is the Go-to Source for POC Education/Advocacy Founded in 2013, POCMA supports the POC channel through education and advocacy. Top-tier marketers will keep their ears to the ground in order to stay fully informed on these new options and deploy those that make sense for their brands.

Marketing 52

Marketing Electronics Doctors Physicians 52

PM360

APRIL 7, 2023

Biopharma companies that prioritize in-person patient engagement, supported by digital and social channels, will be better positioned to meet the needs of patients and thrive in an increasingly competitive landscape. 8th edition, Wadsworth Cengage Learning, 2013. References: 1. Knapp, Mark L. and Hall, Judith A. Kaplan, George A.

Biopharma 52

Biopharma Patients Specialization Networking 52

Pharmaceutical Technology

NOVEMBER 4, 2022

The SME R&D tax credit scheme allows tax relief of up to 33% on qualifying R&D expenditure, which the former PM David Cameron’s cabinet introduced in April 2013. UK’s competitive potential. These are significant to the business and [it] will be catastrophic if we lost them.” says O’Meara.

Pharma 93

Pharma Government Pharmaceutical Medicine 93

Clarivate

APRIL 24, 2023

After Walgreens upped its ownership stake in the primary-care company VillageMD from 30 to 63 percent and then announced plans to operate 1,000 clinics by 2027, the writing was on the wall: to stay competitive and manage costs in CVS’ newly integrated Aetna plan, CVS could benefit by making a larger bid for primary care of its own.

Healthcare 89

Healthcare Healthcare Marketing Physicians 89

Clarify Health

MARCH 17, 2023

While there has been substantial progress since CMS first released hospital charges for inpatient services in 2013, there is still much we do not know. New entrants may better target local healthcare markets or service categories where rates are particularly non-competitive.

Healthcare 52

Healthcare Healthcare Competition Networking 52

CloserIQ

OCTOBER 10, 2018

Founded 2013. Founded 2013. Cybereason’s workplace culture is known to be fast-paced and competitive, with plenty of opportunities for learning. Founded 2013. Salsify offers competitive benefits and a flexible vacation plan. Acquia currently has many open sales positions in Boston. Markforged. 101-250 employees.

Sales 76

Sales Management Education Marketing 76

Pharmaceutical Technology

OCTOBER 25, 2022

Understanding both the significant competitive advantages that FDC products can offer, and the difficulties and potential pitfalls associated with development and manufacturing of FDC drugs in oral solid dosage forms is a critical first step for companies exploring this approach. More FDC products flowing into pharma pipelines.

Manufacturing 52

Manufacturing Physicians Prescription Pharmaceutical 52

Spotio

OCTOBER 21, 2022

Map-based data visualization, location-based insights, and optimization and automation tools are essential for field sales teams to succeed in a rapidly-growing competitive landscape. These tools can guide team members through sales routes and inform managers where their employees are at any given time. Who is SalesRabbit?

Sales 52

Sales Management Leads CRM 52

Spotio

JUNE 6, 2022

Outside Sales Reps Now Spend 89% More Time Selling Remotely Than in 2013. For example : SPOTIO’s Lead Machine gives reps and managers a competitive advantage because they are able to quickly build detailed customer profiles and map territories filled with qualified prospects in minutes. of the sales force.

Sales 111

Sales Prospecting B2B Sales Leads 111

MedCepts

NOVEMBER 7, 2017

Unique, relevant and quality content will provide the medical and healthcare related business a competitive edge. That’s the result of over 3,000 daily visitors to MedCepts back in 2013, and we’re growing while also being challenged by the ever-changing landscape of the world wide web. see image below).

Healthcare 52

Healthcare Healthcare Medical Distribution 52

Clarivate

OCTOBER 7, 2021

Competition is imminent as the CheckMate-76K trial evaluating Bristol-Myers Squibb’s Opdivo in stage IIB-C melanoma patients is also poised to enter this setting. This novel antibody-drug conjugate (ADC)ADC faces much competition, should it be approved.

Patients 91

Patients Safety Marketing Physicians 91

Clarivate

APRIL 18, 2024

Humana is following a similar growth strategy as it sharpens competition with UnitedHealthcare in the Medicare Advantage sector. Michelle La Vone has been with Clarivate Market Access Insights (formerly Decision Resources Group) since 2013. The post How retailers and “payviders” are disrupting U.S.

Retail 52

Retail Healthcare Healthcare Physicians 52

Evolve Your Success

MARCH 28, 2023

I’m not saying anybody can’t, but they’re sure competitive and doing it immediately out of college. Stryker acquired MAKO back in 2013. What we’ve seen is that these positions have become so competitive. Even succeeding in your role has become competitive. I’m in sales. Anybody can do it.”

Medical 52

Medical Sales Medical sales Training 52

Evolve Your Success

JANUARY 23, 2024

Sometimes my competition will take that article and say, “I could plus or minus 10 millimeters.” The patent came out in December 2013. When he called and said it was being published in a JOA out of all articles or publications, I did not know I hit it because I was surprised. It was rough. Ten millimeters was the dome back then.

Medical sales 52

Medical sales Sales Medical Physicians 52

Evolve Your Success

DECEMBER 20, 2022

I finally got on LinkedIn in 2013, and that’s when I decided if the content isn’t out there yet, I’m going to start creating some. I began doing that in 2013 and I told myself at the beginning, I had been a blogger years before and all kinds of different topics. I was shocked that there was almost nothing out there.

Medical sales 52

Medical sales Media Sales Medical sales reps 52